治疗HER2-阳性晚期胃癌的最新进展
Takeshi Kawakami1, Kentaro Yamazaki1
1Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka 411-0934, Japan.
Cancers
|May 11, 2024
概括
新的治疗方法,如trastuzumab deruxtecan和免疫疗法组合,对HER2阳性胃癌具有前景,提供了更好的结果和新的护理标准.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类表皮受体2 (HER2) 阳性晚期胃癌代表了一个显著的亚型,影响大约20%的患者.
- 虽然trastuzumab与化疗结合提供了生存益处,但之前的HER2向疗法在早期或晚期的治疗线路中表现出有限的成功.
- 抗体-药物结合物trastuzumab deruxtecan已经成为一种新的标准,在后一线治疗中证明了它的有效性.
研究的目的:
- 审查目前对HER2阳性晚期胃癌的治疗情况.
- 讨论治疗策略的最新进展,包括抗体-药物联合体和免疫疗法组合.
- 探索管理这种特定癌症亚型的未来方向和前景.
主要方法:
- 对临床试验数据和关于 HER2 阳性胃癌治疗的最新文献的审查.
- 对新型治疗药物和组合药物的疗效和安全性分析.
- 讨论新兴的治疗模式,包括免疫疗法和抗体药物联合体.
主要成果:
- 特拉斯图祖马布德鲁克斯坦已经成为一种新的护理标准,特别是在后期治疗环境中.
- 布罗利祖马布,特拉斯图祖马布和化疗的联合治疗在一线治疗中显示出高响应率,导致FDA迅速批准.
- 进步包括开发新的HER2向剂和结合策略,包括免疫疗法.
结论:
- 治疗HER2阳性胃癌正在迅速发展,随着新药和组合疗法的引入.
- 与HER2向药物结合的免疫疗法代表了改善患者结果的有希望的前沿.
- 持续的研究和开发对于优化治疗策略和解决 HER2 阳性胃癌未满足需求至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:26Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89
01:30Cancer Vaccines
358
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
358
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
371
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
371